tert-Butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate

Catalog No. :
ACGBRW753
CAS No. :
205383-87-5
Molecular Formula :
C16H20N2O3
Molecular Weight :
288.35

IUPAC Name:tert-butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate

tert-Butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$118.00Login to see priceIn stockInquiry
5g95%$488.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate
IUPAC Nametert-butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate
MDL No.MFCD08458288
Molecular FormulaC16H20N2O3
Molecular Weight288.35
SMILESO=C(N1CC2(CC1)C(NC3=C2C=CC=C3)=O)OC(C)(C)C
InChI KeyFHCRLRHLKXXJJZ-UHFFFAOYSA-N
Synonym205383-87-5 | tert-Butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate | Tert-butyl 2-oxospiro[1H-indole-3,3'-pyrrolidine]-1'-carboxylate | 2-Oxo-1,2-dihydro-spiro[indole-3,3'-pyrrolidine]-1'-carboxylic acid tert-butyl ester | MFCD08458288 | Spiro[3H-indole-
CAS No.205383-87-5
PubChem CID11000714

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACGBRW753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFAHO489 route compound structure diagram
    ACFAHO4891803592-37-1 In Stock
  4. Then
  5. ACGBRW753 route product structure diagram
    ACGBRW753205383-87-5 In Stock
Inquiry

2. ACGBRW753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGBRW753 route product structure diagram
    ACGBRW753205383-87-5 In Stock
Inquiry

Comments (0)